172 related articles for article (PubMed ID: 22046092)
1. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Yoon HA; Noh MH; Kim BG; Han JS; Jang JS; Choi SR; Jeong JS; Chun JH
World J Gastroenterol; 2011 Sep; 17(35):4023-30. PubMed ID: 22046092
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
[TBL] [Abstract][Full Text] [Related]
3. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.
Wu WR; Shi XD; Zhang R; Zhu MS; Xu LB; Yu XH; Zeng H; Wang J; Liu C
Int J Clin Exp Pathol; 2014; 7(6):3272-9. PubMed ID: 25031748
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin.
Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N
J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269
[TBL] [Abstract][Full Text] [Related]
6. Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells.
Caolo V; van den Akker NM; Verbruggen S; Donners MM; Swennen G; Schulten H; Waltenberger J; Post MJ; Molin DG
J Biol Chem; 2010 Dec; 285(52):40681-9. PubMed ID: 20959466
[TBL] [Abstract][Full Text] [Related]
7. Delta-like ligand 4-notch blockade and tumor radiation response.
Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
9. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.
Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J
World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223
[TBL] [Abstract][Full Text] [Related]
10. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.
Fukuda D; Aikawa E; Swirski FK; Novobrantseva TI; Kotelianski V; Gorgun CZ; Chudnovskiy A; Yamazaki H; Croce K; Weissleder R; Aster JC; Hotamisligil GS; Yagita H; Aikawa M
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):E1868-77. PubMed ID: 22699504
[TBL] [Abstract][Full Text] [Related]
11. Control of endothelial cell tube formation by Notch ligand intracellular domain interactions with activator protein 1 (AP-1).
Forghany Z; Robertson F; Lundby A; Olsen JV; Baker DA
J Biol Chem; 2018 Jan; 293(4):1229-1242. PubMed ID: 29196606
[TBL] [Abstract][Full Text] [Related]
12. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
[TBL] [Abstract][Full Text] [Related]
13. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.
Yen WC; Fischer MM; Hynes M; Wu J; Kim E; Beviglia L; Yeung VP; Song X; Kapoun AM; Lewicki J; Gurney A; Simeone DM; Hoey T
Clin Cancer Res; 2012 Oct; 18(19):5374-86. PubMed ID: 22952347
[TBL] [Abstract][Full Text] [Related]
14. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.
Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P
Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
Donnem T; Andersen S; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Dec; 116(24):5676-85. PubMed ID: 20737536
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.
Luo Y; Yang ZL; Wang C; Miao X; Liu Z; Li D; Zou Q; Li J; Liang L; Zeng G; Chen S
Tumori; 2017 Nov; 103(6):557-565. PubMed ID: 27174628
[TBL] [Abstract][Full Text] [Related]
18. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of DLL4 expression in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Okumura H; Kurahara H; Uchikado Y; Setoyama T; Kita Y; Kijima Y; Nishizono Y; Nakajo A; Owaki T; Ueno S; Natsugoe S
J Exp Clin Cancer Res; 2013 Jul; 32(1):46. PubMed ID: 23898884
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
Williams CK; Li JL; Murga M; Harris AL; Tosato G
Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
